A retrospective analysis of 81 stage I seminoma patients irradiated at
the Northern Israel Oncology Center between 1968 and 1993 was underta
ken. During this period, 5 (6%) patients relapsed, all outside the ini
tial treatment volume, with a median time of 6.6 (range 1-12) months t
o relapse, Three patients were salvaged with cisplatin-based chemother
apy. The policy of adjuvant radiotherapy resulted in a high probabilit
y of cure and decreased relapse rate, Early relapse is a rare event in
properly irradiated stage I seminoma which is highly curable with a c
isplatin-containing regimen. Recurrences tend to occur outside the tre
ated radiation volume.